Richtlijnen en literatuur

Richtlijnen

Er is op dit moment geen richtlijn voor TLS. 

Literatuur

1. Liu CY et al. A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy. Leuk Res 2005 April;29(4):463-5
2. Cairo MS et al. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 2010 May;149(4):578-86
3. Cairo MS et al. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol 2004 October;127(1):3-11
4. Coiffier B et al. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 2008 June 1;26(16):2767-78
5. Montesinos P et al. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model. Haematologica 2008 January;93(1):67-74
6. Cortes J et al. Control of plasma uric acid in adults at risk for tumor lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone - results of a multicenter phase III study. J Clin Oncol 2010 August 16

Ga terug naar de TLS homepage of lees meer over TLS:

• Inleiding en definitie
• Risico inschatting
• Preventie
• Behandeling
• Beheer en wijzigingenhistorie

Ga terug naar de algemene homepage Behandelprotocollen.